(-)-demecolcine decreases expression ISO BRCA2 (Homo sapiens) 6480464 Demecolcine results in decreased expression of BRCA2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BRCA2 mRNA CTD PMID:22079256 (R)-lipoic acid multiple interactions ISO Brca2 (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BRCA2 mRNA] CTD PMID:23608068 (S)-naringenin increases expression ISO BRCA2 (Homo sapiens) 6480464 naringenin results in increased expression of BRCA2 mRNA CTD PMID:36235125 (S)-naringenin multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BRCA2 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of BRCA2 mRNA CTD PMID:36235125 1,2-dichloroethane decreases expression ISO Brca2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of BRCA2 mRNA CTD PMID:28960355 17alpha-ethynylestradiol increases expression ISO Brca2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of BRCA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Brca2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BRCA2 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO BRCA2 (Homo sapiens) 6480464 Estradiol results in increased expression of BRCA2 mRNA CTD PMID:19167446 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO BRCA2 (Homo sapiens) 6480464 Metribolone results in increased expression of BRCA2 mRNA CTD PMID:17010196 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Brca2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Brca2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Brca2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BRCA2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BRCA2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO BRCA2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of BRCA2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Brca2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BRCA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Brca2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BRCA2 mRNA CTD PMID:17942748 4-hydroxyphenyl retinamide decreases expression ISO BRCA2 (Homo sapiens) 6480464 Fenretinide results in decreased expression of BRCA2 mRNA CTD PMID:16570282 acetamide increases expression EXP 6480464 acetamide results in increased expression of BRCA2 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO BRCA2 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of BRCA2 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BRCA2 mRNA CTD PMID:23630614 aflatoxin B1 increases expression ISO Brca2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of BRCA2 mRNA CTD PMID:19770486 all-trans-retinoic acid affects expression ISO BRCA2 (Homo sapiens) 6480464 Tretinoin affects the expression of BRCA2 mRNA CTD PMID:15498508 all-trans-retinoic acid decreases expression ISO BRCA2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of BRCA2 mRNA CTD PMID:15498508 and PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BRCA2 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO BRCA2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of BRCA2 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO Brca2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BRCA2 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO BRCA2 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to BRCA2 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO BRCA2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BRCA2 mRNA CTD PMID:20471514 arsenous acid multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of BRCA2 mRNA CTD PMID:25913414 asbestos affects response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 alternative form affects the susceptibility to Asbestos CTD PMID:28687356 azathioprine decreases expression ISO BRCA2 (Homo sapiens) 6480464 Azathioprine results in decreased expression of BRCA2 mRNA CTD PMID:22623647 benzene increases response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 gene SNP results in increased susceptibility to Benzene CTD PMID:16728435 benzene affects expression ISO BRCA2 (Homo sapiens) 6480464 Benzene affects the expression of BRCA2 mRNA CTD PMID:16188086 benzo[a]pyrene increases expression ISO BRCA2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BRCA2 mRNA CTD PMID:28461126 and PMID:32234424 benzo[a]pyrene affects methylation ISO BRCA2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of BRCA2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Brca2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BRCA2 mRNA CTD PMID:20504355 and PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO BRCA2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 Benzo[ghi]perylene increases expression ISO BRCA2 (Homo sapiens) 6480464 1 and 12-benzoperylene results in increased expression of BRCA2 mRNA CTD PMID:31518672 benzophenanthridine decreases expression ISO BRCA2 (Homo sapiens) 6480464 Benzophenanthridines analog results in decreased expression of BRCA2 mRNA CTD PMID:23117580 bis(2-chloroethyl) sulfide multiple interactions ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein inhibits the reaction [Mustard Gas affects the localization of RAD51 protein] more ... CTD PMID:20435105 bis(2-chloroethyl) sulfide decreases response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein results in decreased susceptibility to Mustard Gas CTD PMID:20435105 bisphenol A increases expression ISO BRCA2 (Homo sapiens) 6480464 bisphenol A results in increased expression of BRCA2 mRNA and bisphenol A results in increased expression of BRCA2 protein CTD PMID:22576693 and PMID:25933419 bisphenol A decreases expression ISO Brca2 (Mus musculus) 6480464 bisphenol A results in decreased expression of BRCA2 mRNA CTD PMID:32156529 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BRCA2 gene CTD PMID:28505145 bisphenol A multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BRCA2 mRNA more ... CTD PMID:25933419 and PMID:36235125 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BRCA2 mRNA CTD PMID:25181051 bortezomib decreases expression ISO BRCA2 (Homo sapiens) 6480464 Bortezomib results in decreased expression of BRCA2 mRNA CTD PMID:21917757 bortezomib multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Bortezomib] results in increased expression of BRCA2 mRNA CTD PMID:25913414 butanal decreases expression ISO BRCA2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of BRCA2 mRNA CTD PMID:26079696 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of BRCA2 promoter CTD PMID:22457795 cadmium dichloride increases expression ISO BRCA2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of BRCA2 mRNA CTD PMID:12160620 and PMID:26472689 cadmium dichloride multiple interactions ISO Brca2 (Mus musculus) 6480464 MT1 affects the reaction [Cadmium Chloride results in decreased expression of BRCA2 mRNA] and MT2 affects the reaction [Cadmium Chloride results in decreased expression of BRCA2 mRNA] CTD PMID:11958953 cadmium dichloride decreases expression ISO Brca2 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of BRCA2 mRNA CTD PMID:11958953 caffeine affects phosphorylation ISO BRCA2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of BRCA2 protein CTD PMID:35688186 calcitriol decreases expression ISO BRCA2 (Homo sapiens) 6480464 Calcitriol results in decreased expression of BRCA2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BRCA2 mRNA CTD PMID:21592394 camptothecin decreases expression ISO BRCA2 (Homo sapiens) 6480464 Camptothecin results in decreased expression of BRCA2 mRNA CTD PMID:10344722 cannabidiol multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of BRCA2 mRNA] and Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in increased expression of BRCA2 mRNA] CTD PMID:32992648 cannabidiol decreases expression ISO BRCA2 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of BRCA2 mRNA CTD PMID:32992648 and PMID:36519830 carbon nanotube increases expression ISO Brca2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of BRCA2 mRNA CTD PMID:25554681 chlorpyrifos decreases expression ISO Brca2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of BRCA2 mRNA CTD PMID:37019170 choline multiple interactions ISO Brca2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BRCA2 gene CTD PMID:20938992 chromium(6+) affects expression ISO Brca2 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of BRCA2 mRNA CTD PMID:28472532 chromium(6+) affects localization ISO BRCA2 (Homo sapiens) 6480464 chromium hexavalent ion affects the localization of BRCA2 protein CTD PMID:27449664 cisplatin decreases response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein results in decreased susceptibility to Cisplatin and BRCA2 results in decreased susceptibility to Cisplatin CTD PMID:21385444 and PMID:21633166 cisplatin multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of BRCA2 mRNA CTD PMID:30871063 cisplatin increases expression ISO BRCA2 (Homo sapiens) 6480464 Cisplatin results in increased expression of BRCA2 mRNA CTD PMID:27594783 coumestrol multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO BRCA2 (Homo sapiens) 6480464 Coumestrol results in increased expression of BRCA2 mRNA CTD PMID:19167446 CU-O LINKAGE increases expression ISO BRCA2 (Homo sapiens) 6480464 cupric oxide results in increased expression of BRCA2 mRNA CTD PMID:32285662 CX-5461 affects response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein affects the susceptibility to CX 5461 CTD PMID:28211448 CX-5461 affects response to substance ISO Brca2 (Mus musculus) 6480464 BRCA2 protein affects the susceptibility to CX 5461 CTD PMID:28211448 CX-5461 multiple interactions ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein affects the reaction [CX 5461 results in increased expression of TP53BP1 protein] and BRCA2 protein affects the reaction [CX 5461 results in increased phosphorylation of RPA2 protein] CTD PMID:28211448 cycloheximide multiple interactions ISO BRCA2 (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA2 mRNA] CTD PMID:10344722 cyclosporin A decreases expression ISO BRCA2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of BRCA2 mRNA CTD PMID:20106945 more ... cylindrospermopsin decreases expression ISO BRCA2 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of BRCA2 mRNA CTD PMID:23726867 cytarabine increases expression ISO BRCA2 (Homo sapiens) 6480464 Cytarabine results in increased expression of BRCA2 mRNA CTD PMID:19194470 Decamethylcyclopentasiloxane decreases expression ISO BRCA2 (Homo sapiens) 6480464 decamethylcyclopentasiloxane results in decreased expression of BRCA2 mRNA CTD PMID:27601420 diarsenic trioxide multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of BRCA2 mRNA CTD PMID:25913414 diarsenic trioxide decreases expression ISO BRCA2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BRCA2 mRNA CTD PMID:20471514 dibenzofuran decreases expression EXP 6480464 dibenzofuran analog results in decreased expression of BRCA2 mRNA CTD PMID:20566336 dibutyl phthalate decreases expression ISO Brca2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of BRCA2 mRNA CTD PMID:17361019 more ... dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of BRCA2 mRNA CTD PMID:26476374 dioxygen multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of BRCA2 mRNA] more ... CTD PMID:32992648 dioxygen decreases expression ISO BRCA2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of BRCA2 mRNA CTD PMID:26516004 dioxygen multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BRCA2 mRNA] CTD PMID:26476374 disodium selenite decreases expression ISO BRCA2 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of BRCA2 mRNA CTD PMID:10344722 doxorubicin decreases expression ISO BRCA2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BRCA2 mRNA CTD PMID:10344722 and PMID:30031762 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of BRCA2 protein CTD PMID:28818578 doxorubicin multiple interactions ISO Brca2 (Mus musculus) 6480464 Lovastatin inhibits the reaction [Doxorubicin results in increased expression of BRCA2 mRNA] CTD PMID:22712078 doxorubicin increases expression ISO Brca2 (Mus musculus) 6480464 Doxorubicin results in increased expression of BRCA2 mRNA CTD PMID:22712078 endosulfan increases expression ISO BRCA2 (Homo sapiens) 6480464 Endosulfan results in increased expression of BRCA2 protein CTD PMID:29705383 endosulfan decreases expression ISO BRCA2 (Homo sapiens) 6480464 Endosulfan results in decreased expression of BRCA2 mRNA CTD PMID:30090376 endosulfan multiple interactions ISO BRCA2 (Homo sapiens) 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Endosulfan affects the expression of BRCA2 mRNA] CTD PMID:29705383 endosulfan affects expression ISO BRCA2 (Homo sapiens) 6480464 Endosulfan affects the expression of BRCA2 mRNA CTD PMID:29705383 Enterolactone multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA CTD PMID:19167446 ethanol decreases expression ISO Brca2 (Mus musculus) 6480464 Ethanol results in decreased expression of BRCA2 mRNA CTD PMID:35149083 folic acid multiple interactions ISO Brca2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BRCA2 gene CTD PMID:20938992 folic acid decreases expression ISO BRCA2 (Homo sapiens) 6480464 Folic Acid results in decreased expression of BRCA2 mRNA CTD PMID:21867686 furan increases expression EXP 6480464 furan results in increased expression of BRCA2 mRNA CTD PMID:20562052 and PMID:22079235 genistein increases expression ISO BRCA2 (Homo sapiens) 6480464 Genistein results in increased expression of BRCA2 mRNA and Genistein results in increased expression of BRCA2 protein CTD PMID:16434996 genistein multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA2 protein CTD PMID:16434996 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BRCA2 mRNA CTD PMID:33387578 geraniol decreases expression ISO BRCA2 (Homo sapiens) 6480464 geraniol results in decreased expression of BRCA2 mRNA CTD PMID:27683099 glycidyl methacrylate decreases expression ISO BRCA2 (Homo sapiens) 6480464 glycidyl methacrylate results in decreased expression of BRCA2 protein CTD PMID:36641056 gold atom multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA CTD PMID:28433809 gold atom decreases expression ISO BRCA2 (Homo sapiens) 6480464 Gold analog results in decreased expression of BRCA2 mRNA CTD PMID:36057382 gold(0) multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA CTD PMID:28433809 gold(0) decreases expression ISO BRCA2 (Homo sapiens) 6480464 Gold analog results in decreased expression of BRCA2 mRNA CTD PMID:36057382 hexamethylcyclotrisiloxane decreases expression ISO BRCA2 (Homo sapiens) 6480464 hexamethylcyclotrisiloxane results in decreased expression of BRCA2 mRNA CTD PMID:27601420 imiquimod decreases expression ISO Brca2 (Mus musculus) 6480464 imiquimod results in decreased expression of BRCA2 mRNA CTD PMID:21878529 indole-3-methanol increases expression ISO BRCA2 (Homo sapiens) 6480464 indole-3-carbinol results in increased expression of BRCA2 mRNA and indole-3-carbinol results in increased expression of BRCA2 protein CTD PMID:16434996 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of BRCA2 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA2 protein CTD PMID:16434996 iron dichloride decreases expression ISO BRCA2 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of BRCA2 mRNA CTD PMID:35984750 L-methionine multiple interactions ISO Brca2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BRCA2 gene CTD PMID:20938992 Lasiocarpine multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA2 mRNA CTD PMID:33884520 Lasiocarpine increases expression ISO BRCA2 (Homo sapiens) 6480464 lasiocarpine results in increased expression of BRCA2 mRNA CTD PMID:32234424 linsidomine increases oxidation EXP 6480464 linsidomine results in increased oxidation of BRCA2 protein CTD PMID:28086193 lipoic acid multiple interactions ISO Brca2 (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BRCA2 mRNA] CTD PMID:23608068 lipopolysaccharide multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of BRCA2 mRNA CTD PMID:35811015 lithocholic acid decreases response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein results in decreased susceptibility to Lithocholic Acid CTD PMID:20028873 lovastatin multiple interactions ISO Brca2 (Mus musculus) 6480464 Lovastatin inhibits the reaction [Doxorubicin results in increased expression of BRCA2 mRNA] CTD PMID:22712078 lucanthone decreases expression ISO BRCA2 (Homo sapiens) 6480464 Lucanthone results in decreased expression of BRCA2 mRNA CTD PMID:21148553 methyl methanesulfonate increases expression ISO BRCA2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of BRCA2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO BRCA2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of BRCA2 mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO BRCA2 (Homo sapiens) 6480464 methylselenic acid results in increased expression of BRCA2 mRNA CTD PMID:12517777 monocrotaline multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which affects the expression of BRCA2 mRNA CTD PMID:33884520 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO BRCA2 (Homo sapiens) 6480464 N more ... CTD PMID:33645215 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO BRCA2 (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in increased expression of BRCA2 mRNA CTD PMID:12634122 N-nitrosodiethylamine increases expression ISO Brca2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of BRCA2 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO Brca2 (Mus musculus) 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA2 mRNA] CTD PMID:17854601 nitrogen mustard multiple interactions ISO BRCA2 (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA2 mRNA] CTD PMID:10344722 nitrogen mustard increases expression ISO BRCA2 (Homo sapiens) 6480464 Nitrogen Mustard Compounds results in increased expression of BRCA2 mRNA CTD PMID:27342729 nitrogen mustard decreases expression ISO BRCA2 (Homo sapiens) 6480464 Nitrogen Mustard Compounds results in decreased expression of BRCA2 mRNA CTD PMID:10344722 O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of BRCA2 mRNA CTD PMID:26011634 octamethylcyclotetrasiloxane decreases expression ISO BRCA2 (Homo sapiens) 6480464 octamethylcyclotetrasiloxane results in decreased expression of BRCA2 mRNA CTD PMID:27601420 olaparib affects response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 affects the susceptibility to olaparib CTD PMID:21633166 ozone multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of BRCA2 mRNA] more ... CTD PMID:32992648 paracetamol increases expression ISO BRCA2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of BRCA2 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BRCA2 mRNA CTD PMID:33387578 paraquat decreases expression ISO Brca2 (Mus musculus) 6480464 Paraquat results in decreased expression of BRCA2 mRNA CTD PMID:28012437 PCB138 multiple interactions ISO Brca2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 phenethyl isothiocyanate decreases expression ISO BRCA2 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of BRCA2 mRNA CTD PMID:26678675 phenobarbital affects expression ISO Brca2 (Mus musculus) 6480464 Phenobarbital affects the expression of BRCA2 mRNA CTD PMID:19136022 pirinixic acid affects expression ISO Brca2 (Mus musculus) 6480464 pirinixic acid affects the expression of BRCA2 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO Brca2 (Mus musculus) 6480464 pirinixic acid results in increased expression of BRCA2 mRNA CTD PMID:23811191 potassium chromate multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BRCA2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO BRCA2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of BRCA2 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO Brca2 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of BRCA2 mRNA CTD PMID:23608068 potassium dichromate multiple interactions ISO Brca2 (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BRCA2 mRNA] CTD PMID:23608068 pregnenolone 16alpha-carbonitrile multiple interactions ISO Brca2 (Mus musculus) 6480464 [1 more ... CTD PMID:23626729 promethazine decreases expression EXP 6480464 Promethazine results in decreased expression of BRCA2 mRNA CTD PMID:26011634 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BRCA2 mRNA] CTD PMID:26476374 quercetin decreases expression ISO Brca2 (Mus musculus) 6480464 Quercetin results in decreased expression of BRCA2 mRNA CTD PMID:25862958 quercetin increases expression ISO BRCA2 (Homo sapiens) 6480464 Quercetin results in increased expression of BRCA2 mRNA CTD PMID:15309432 resveratrol increases expression ISO BRCA2 (Homo sapiens) 6480464 resveratrol results in increased expression of BRCA2 mRNA CTD PMID:15149879 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of BRCA2 mRNA CTD PMID:33775663 resveratrol decreases expression ISO BRCA2 (Homo sapiens) 6480464 resveratrol results in decreased expression of BRCA2 mRNA CTD PMID:25667456 resveratrol multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of BRCA2 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of BRCA2 mRNA CTD PMID:19167446 and PMID:23557933 resveratrol affects expression EXP 6480464 resveratrol affects the expression of BRCA2 mRNA CTD PMID:15748624 riddelliine multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRCA2 mRNA CTD PMID:33884520 rotenone increases expression ISO BRCA2 (Homo sapiens) 6480464 Rotenone results in increased expression of BRCA2 mRNA CTD PMID:18191903 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of BRCA2 mRNA CTD PMID:35811015 sodium arsenite affects expression ISO Brca2 (Mus musculus) 6480464 sodium arsenite affects the expression of BRCA2 mRNA CTD PMID:16507464 sodium arsenite increases expression ISO BRCA2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of BRCA2 mRNA CTD PMID:12760830 and PMID:29301061 succimer multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BRCA2 mRNA CTD PMID:26378955 sunitinib decreases expression ISO BRCA2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of BRCA2 mRNA CTD PMID:31533062 tamibarotene affects expression ISO BRCA2 (Homo sapiens) 6480464 tamibarotene affects the expression of BRCA2 mRNA CTD PMID:15498508 tamibarotene decreases expression ISO BRCA2 (Homo sapiens) 6480464 tamibarotene results in decreased expression of BRCA2 mRNA CTD PMID:15498508 temozolomide decreases response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 protein results in decreased susceptibility to temozolomide CTD PMID:20028873 testosterone multiple interactions ISO BRCA2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BRCA2 mRNA CTD PMID:21592394 testosterone decreases expression ISO BRCA2 (Homo sapiens) 6480464 Testosterone results in decreased expression of BRCA2 mRNA CTD PMID:21592394 thapsigargin increases expression ISO BRCA2 (Homo sapiens) 6480464 Thapsigargin results in increased expression of BRCA2 mRNA and Thapsigargin results in increased expression of BRCA2 protein CTD PMID:16434996 thimerosal increases expression ISO BRCA2 (Homo sapiens) 6480464 Thimerosal results in increased expression of BRCA2 mRNA CTD PMID:27188386 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of BRCA2 mRNA CTD PMID:34492290 trichostatin A decreases expression ISO BRCA2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of BRCA2 mRNA CTD PMID:23770000 trimellitic anhydride increases expression ISO Brca2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of BRCA2 mRNA CTD PMID:19042947 triptonide affects expression ISO Brca2 (Mus musculus) 6480464 triptonide affects the expression of BRCA2 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO Brca2 (Mus musculus) 6480464 trovafloxacin results in decreased expression of BRCA2 mRNA CTD PMID:35537566 tunicamycin increases expression ISO BRCA2 (Homo sapiens) 6480464 Tunicamycin results in increased expression of BRCA2 protein CTD PMID:16434996 valproic acid affects expression ISO BRCA2 (Homo sapiens) 6480464 Valproic Acid affects the expression of BRCA2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO BRCA2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of BRCA2 mRNA CTD PMID:23179753 and PMID:27188386 valproic acid increases expression ISO Brca2 (Mus musculus) 6480464 Valproic Acid results in increased expression of BRCA2 mRNA CTD PMID:24913804 valproic acid decreases expression ISO Brca2 (Mus musculus) 6480464 Valproic Acid results in decreased expression of BRCA2 mRNA CTD PMID:24913804 veliparib affects response to substance ISO BRCA2 (Homo sapiens) 6480464 BRCA2 affects the susceptibility to veliparib CTD PMID:21633166 vorinostat increases expression ISO BRCA2 (Homo sapiens) 6480464 vorinostat results in increased expression of BRCA2 mRNA CTD PMID:27188386 zinc atom decreases expression ISO BRCA2 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of BRCA2 mRNA CTD PMID:18356318 zinc(0) decreases expression ISO BRCA2 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of BRCA2 mRNA CTD PMID:18356318 zoledronic acid increases expression ISO BRCA2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of BRCA2 mRNA CTD PMID:20977926